Chemical receptor linked to breast cancer spread
Key points
- Increased levels of a cell chemical receptor called CXCR4 is needed for the spread of certain hereditary breast cancers, researchers report in the journal Cancer Cell.
- Why these "HER2-positive" cancers preferentially travel to organs such as the lung, liver and bones has "always been a puzzle," senior author Dr.
- Anderson Cancer Center in Houston, and colleagues established that CXCR4 plays an important role in the spread of hereditary breast cancer.
- CXCR4 latches on to chemical signals that are emitted by other cells.
Increased levels of a cell chemical receptor called CXCR4 is needed for the spread of certain hereditary breast cancers, researchers report in the journal Cancer Cell.
Why these "HER2-positive" cancers preferentially travel to organs such as the lung, liver and bones has "always been a puzzle," senior author Dr. Mien-Chie Hung said in a statement. "We have now explained it biochemically, and hope this leads to strategies that prevent such metastasis."
Hung, from M. D. Anderson Cancer Center in Houston, and colleagues established that CXCR4 plays an important role in the spread of hereditary breast cancer. Levels of this receptor were much higher in HER2-positive cancer cells than in other cells. Moreover, as levels of the HER2 protein increased, so did CXCR4 levels.
CXCR4 latches on to chemical signals that are emitted by other cells. "HER2 turns on and then magnifies the ability of (breast) cancer cells to zero in on organs" that release the chemical that binds to CXCR4, Hung explained.
Because CXCR4 levels have been linked to breast cancer survival, the new findings "will have important clinical implications," the authors write.
SOURCE: Cancer Cell, November 2004.
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsLong-Term Use of Estrogen Hormone Therapy Linked to Higher Risk for Breast Cancer
In a landmark study, researchers have linked the long-term use of estrogen plus progesterone and estrogen-only hormone therapy with a higher risk for developing breast cancer. “It’s already been confirmed that patients…
2 April 2012
NewsDietary Cadmium May Be Linked with Breast Cancer Risk
Dietary cadmium, a toxic metal widely dispersed in the environment and found in many farm fertilizers, may lead to an increased risk of breast cancer, according to a study published in Cancer Research, a journal of the…
16 March 2012
NewsUnderstanding the role of androgen receptor signaling in breast cancer
The ovarian production of steroid hormones throughout a woman’s lifetime is ample and varied, with important changes during different life stages. Estrogens are the most prominent ovarian hormones in terms of their…
17 February 2012
